Is elimination of HCV in 2030 realistic in Central Europe

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F21%3A00081151" target="_blank" >RIV/00023001:_____/21:00081151 - isvavai.cz</a>

Výsledek na webu

<a href="https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.14834" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1111/liv.14834</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/liv.14834" target="_blank" >10.1111/liv.14834</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Is elimination of HCV in 2030 realistic in Central Europe

Popis výsledku v původním jazyce

According to the recent data presented by Central-European HCV experts, the estimated prevalence of HCV is between 0.2% and 1.7% in certain countries in this region. There are no financial limitations to access to treatment in most countries. Patients in these countries have access to at least one pangenotypic regimen. The most common barriers to the elimination of HCV in Central Europe are a lack of established national screening programmes and limited political commitment to the elimination of HCV. Covid-19 has significantly affected the number of patients who have been diagnosed and treated, thus, delaying the potential elimination of HCV. These data suggest that the elimination of HCV elimination projected by WHO before 2030 will not be possible in the Central Europe.

Název v anglickém jazyce

Is elimination of HCV in 2030 realistic in Central Europe

Popis výsledku anglicky

According to the recent data presented by Central-European HCV experts, the estimated prevalence of HCV is between 0.2% and 1.7% in certain countries in this region. There are no financial limitations to access to treatment in most countries. Patients in these countries have access to at least one pangenotypic regimen. The most common barriers to the elimination of HCV in Central Europe are a lack of established national screening programmes and limited political commitment to the elimination of HCV. Covid-19 has significantly affected the number of patients who have been diagnosed and treated, thus, delaying the potential elimination of HCV. These data suggest that the elimination of HCV elimination projected by WHO before 2030 will not be possible in the Central Europe.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30219 - Gastroenterology and hepatology

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Liver international

ISSN

1478-3223

e-ISSN

—

Svazek periodika

41

Číslo periodika v rámci svazku

Supplement 1

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

5

Strana od-do

56-60

Kód UT WoS článku

000664028900009

EID výsledku v databázi Scopus

2-s2.0-85108239114